Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > They had better host a call tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by TH1902on Dec 01, 2022 7:45pm

203 Views

Post# 35144961

RE:RE:They had better host a call tomorrow

Only 1,550 shares traded AH. Nothing in the stock for Cancer but we will see...can't deny this is disappointing ESPECIALLY given the words from leadership about THE KEY very recently...

Would this be enough to start the CLASS ACTION LAWSUITS or at least get the Ambulance chasers out in full force to further the damage to the stock/company?

https://www.marketwatch.com/investing/stock/thtx